RHJA
Rice Hall James & Associates’s Vanda Pharmaceuticals VNDA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-60,309
| Closed | -$990K | – | 285 |
|
2019
Q4 | $990K | Sell |
60,309
-233
| -0.4% | -$3.83K | 0.03% | 233 |
|
2019
Q3 | $804K | Buy |
60,542
+1,615
| +3% | +$21.4K | 0.03% | 235 |
|
2019
Q2 | $830K | Buy |
58,927
+3,017
| +5% | +$42.5K | 0.03% | 243 |
|
2019
Q1 | $1.03M | Buy |
55,910
+17,646
| +46% | +$325K | 0.03% | 247 |
|
2018
Q4 | $1M | Buy |
38,264
+13,649
| +55% | +$357K | 0.04% | 246 |
|
2018
Q3 | $565K | Sell |
24,615
-108
| -0.4% | -$2.48K | 0.02% | 267 |
|
2018
Q2 | $471K | Buy |
24,723
+421
| +2% | +$8.02K | 0.02% | 270 |
|
2018
Q1 | $409K | Sell |
24,302
-3,943
| -14% | -$66.4K | 0.02% | 271 |
|
2017
Q4 | $429K | Buy |
28,245
+323
| +1% | +$4.91K | 0.02% | 277 |
|
2017
Q3 | $500K | Buy |
27,922
+19
| +0.1% | +$340 | 0.02% | 263 |
|
2017
Q2 | $455K | Buy |
27,903
+279
| +1% | +$4.55K | 0.02% | 262 |
|
2017
Q1 | $387K | Buy |
27,624
+739
| +3% | +$10.4K | 0.02% | 276 |
|
2016
Q4 | $429K | Buy |
26,885
+4,542
| +20% | +$72.5K | 0.02% | 269 |
|
2016
Q3 | $372K | Buy |
22,343
+274
| +1% | +$4.56K | 0.02% | 271 |
|
2016
Q2 | $247K | Sell |
22,069
-188
| -0.8% | -$2.1K | 0.01% | 283 |
|
2016
Q1 | $186K | Sell |
22,257
-340
| -2% | -$2.84K | 0.01% | 290 |
|
2015
Q4 | $210K | Buy |
22,597
+631
| +3% | +$5.86K | 0.01% | 294 |
|
2015
Q3 | $248K | Sell |
21,966
-995
| -4% | -$11.2K | 0.02% | 287 |
|
2015
Q2 | $291K | Sell |
22,961
-2,408
| -9% | -$30.5K | 0.02% | 289 |
|
2015
Q1 | $236K | Buy |
25,369
+655
| +3% | +$6.09K | 0.01% | 302 |
|
2014
Q4 | $354K | Buy |
24,714
+357
| +1% | +$5.11K | 0.02% | 284 |
|
2014
Q3 | $253K | Buy |
24,357
+303
| +1% | +$3.15K | 0.02% | 282 |
|
2014
Q2 | $389K | Buy |
24,054
+350
| +1% | +$5.66K | 0.03% | 274 |
|
2014
Q1 | $385K | Buy |
+23,704
| New | +$385K | 0.03% | 274 |
|